Research Explorer uses third party
cookies
to generate statistics about the use of the site. For that we need your permission.
I agree
Close
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Kaat Durinck
Profile
Projects
Publications
Activities
7
Results
As
Promotor
01 January 2022 → Ongoing
Building a next-generation precision oncology platform for childhood cancer
Funding: Regional and community funding: Special Research Fund
As
Copromotor
01 October 2019 → Ongoing
The PHF6 - TLX1 cooperativity and the IL7R-JAK3 signaling axis as drug target in PHF6 deficient TALL.
Funding: Regional and community funding: Special Research Fund
As
Fellow
01 October 2016 → 30 September 2019
Identification of novel therapeutic targets through multi-level (epi) genomic landscaping of replicative stress resistant neuroblastoma
Funding: Regional and community funding: Special Research Fund
01 January 2018 → 31 December 2018
The chromatin modifier BRD3 as a key novel player in DNA repair and vulnerable therapeutic target in neuroblastoma
Funding: Research Foundation - Flanders (FWO)
01 January 2015 → 31 December 2015
The PHF6 - TLX1 cooperativity and the IL7R-JAK3 signaling axis as drug target in PHF6 deficient T-ALL
Funding: Research Foundation - Flanders (FWO)
01 October 2018 → 31 August 2021
The role of BRCA1 as oncogenic replicative stress resistor in MYCN driven neuroblastoma
Funding: Research Foundation - Flanders (FWO)
01 October 2010 → 05 January 2016
Unraveling the role of PHF6 in normal T cell development and T-cell acute lymphoblastic leukemia
Funding: Regional and community funding: IWT/VLAIO
As
Contact person
01 January 2022 → Ongoing
Building a next-generation precision oncology platform for childhood cancer